Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com.
View Top Employees from Teva Pharmaceutical Industries Ltd IsraelLooking for a particular Teva Pharmaceutical Industries Ltd Israel employee's phone or email?
The Teva Pharmaceutical Industries Ltd Israel annual revenue was $21.9 billion in 2024.
Eyal Danieli is the Senior Director Business Development of Teva Pharmaceutical Industries Ltd Israel.
961 people are employed at Teva Pharmaceutical Industries Ltd Israel.
Teva Pharmaceutical Industries Ltd Israel is based in Petah Tiqwa, Central District.
The NAICS codes for Teva Pharmaceutical Industries Ltd Israel are [541, 551112, 3254, 32541, 54171, 54, 55, 541711, 551, 32, 325, 5511, 325412, 55111, 5417].
The SIC codes for Teva Pharmaceutical Industries Ltd Israel are [671, 28, 87, 283, 6719, 873, 8731, 2834, 67].